UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation
Open Access
- 1 June 2022
- journal article
- research article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 13 (3) , 1444-1453
Abstract
Original Article UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation Jing-Zhu Cao, Gang Nie, Hao Hu, Xiao Zhang, Chen-Ming Ni, Zhi-Ping Huang, Guang-Lei Qiao, Liu OuyangKeywords
This publication has 25 references indexed in Scilit:
- The role of ubiquitin modification in the regulation of p53Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- MUC15 Inhibits Dimerization of EGFR and PI3K–AKT Signaling and Is Associated With Aggressive Hepatocellular Carcinomas in PatientsGastroenterology, 2013
- Impact of Tumor Grade on Pancreatic Cancer Prognosis: Validation of a Novel TNMG Staging SystemAnnals of Surgical Oncology, 2013
- Ubiquitination and selective autophagyCell Death & Differentiation, 2012
- Pancreatic cancerThe Lancet, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular TrendsJournal of Thoracic Oncology, 2008
- The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implicationsEuropean Journal of Cancer, 2004
- Pancreatic cancerThe Lancet, 2004
- Mechanisms Underlying UbiquitinationAnnual Review of Biochemistry, 2001